Anavex Life Sciences Corp to Discuss ANAVEX®3-71 Phase 1 Top Line Data Call Transcript
Thank you, and good morning, everyone. Welcome to the Anavex Life Sciences ANAVEX-3-71 Phase I top line data conference call. My name is Clint Tomlinson, and I will be your host for today's call. (Operator Instructions)
During this session, if you would like to speak and ask a question, please use the raise your hand button on the bottom. However, if you prefer to leave a question in writing, please use the Q&A button on the bottom right. Please note that this conference is being recorded.
The call will be available for replay on Anavex's website at www.anavex.com. With us today is Dr. Christopher Missling, President and Chief Executive Officer; and Dr. Ed Hammond, Chief Medical Officer.
Before we begin, please note that during the conference call, the company will make some projections and forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |